Eyegate Pharmaceuticals Inc (EYEGW)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 16.01M | 20k | 996k |
営業利益 | -2.64M | -1.92M | -2.63M | -5.92M | -2.12M | 13.22M | -2.53M | -3.71M |
税引前収入 | -2.61M | -1.87M | -2.61M | -5.76M | -2.18M | 13.45M | -2.22M | -3.41M |
純利益 | -2.5M | -1.87M | -2.61M | -6.29M | -2.27M | 13.45M | -2.22M | -3.41M |
優先配当 | 0 | 0 | 0 | -531k | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -2.63M | -1.9M | -2.65M | -5.82M | -2.21M | 13.23M | -2.54M | -3.77M |
EBITDA | -2.63M | -1.91M | -2.61M | -4M | -2.11M | 13.23M | -2.53M | -1.7M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 669k | 408k | 1.65M | 2.69M | 12k | 0 | 0 | 0 |
営業利益 | -13.35M | -14.56M | -10.84M | -7.11M | -8.21M | -16.94M | -12.31M | -12.59M |
税引前収入 | -13.34M | -14.56M | -10.73M | -7M | -8.08M | -16.7M | -13.7M | -12.42M |
純利益 | -13.34M | -13.22M | -10.81M | -7.1M | -8.09M | -16.4M | -13.58M | -13.05M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.306 | -0.261 | -0.14 | -0.189 | -0.207 | -0.355 | -0.385 | -0.317 |
EBIT | -13.35M | -14.56M | -10.84M | -7.11M | -8.21M | -16.97M | -12.31M | -12.59M |
EBITDA | -13.34M | -14.54M | -10.81M | -7.06M | -8.18M | -10.63M | -12.27M | -10.63M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約